Effects of Mycoplasma pneumoniae infection on sphingolipid metabolism in human lung carcinoma A549 cells

Microbial Pathogenesis

Volumn 46, Issue 2, 2009, Pages 63-72

  Yu, Yuanyuan ^a   Sun, Gongping ^b   Liu, Guangyi ^b   Wang, Yingshuo ^a   Shao, Zhengping ^b   Chen, Zhimin ^a   Yang, Jun ^b,c,d  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d Zhejiang California International NanoSystems Institute   (China)

Author keywords

Lipidomics; MALDI TOF MS; Mycoplasma pneumoniae; Sphingolipids

Indexed keywords

CERAMIDE; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; LIPID METABOLISM; LUNG CARCINOMA; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL;

CELL LINE, TUMOR; EPITHELIAL CELLS; HUMANS; LUNG; MYCOPLASMA PNEUMONIAE; SERINE C-PALMITOYLTRANSFERASE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPHINGOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE;

BACTERIA (MICROORGANISMS); MYCOPLASMA PNEUMONIAE;

EID: 58549087336     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2008.10.014     Document Type: Article

References (38)

1. Yang J., Yu Y., Sun S., and Duerksen-Hughes P.J. Ceramide and other sphingolipids in cellular responses. Cell Biochem Biophys 40 (2004) 323-350
2. Waites K.B., and Talkington D.F. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17 (2004) 697-728
3. Nisar N., Guleria R., Kumar S., Chand Chawla T., and Ranjan Biswas N. Mycoplasma pneumoniae and its role in asthma. Postgrad Med J 83 (2007) 100-104
4. Hardy R.D., Jafri H.S., Olsen K., Hatfield J., Iglehart J., Rogers B.B., et al. Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease. Infect Immun 70 (2002) 649-654
5. Yang J., Hooper W.C., Phillips D.J., and Talkington D.F. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect Immun 70 (2002) 3649-3655
6. Koga M., Gilbert M., Li J., Koike S., Takahashi M., Furukawa K., et al. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64 (2005) 1605-1611
7. Susuki K., Odaka M., Mori M., Hirata K., and Yuki N. Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology 62 (2004) 949-956
8. Yuki N. Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 35 (2007) 691-711
9. El Alwani M., Wu B.X., Obeid L.M., and Hannun Y.A. Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol Ther 112 (2006) 171-183
10. Hanada K. Sphingolipids in infectious diseases. Jpn J Infect Dis 58 (2005) 131-148
11. Heung L.J., Luberto C., and Del Poeta M. Role of sphingolipids in microbial pathogenesis. Infect Immun 74 (2006) 28-39
12. Grassme H., Jendrossek V., Riehle A., von Kurthy G., Berger J., Schwarz H., et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9 (2003) 322-330
13. Luberto C., Stonehouse M.J., Collins E.A., Marchesini N., El-Bawab S., Vasil A.I., et al. Purification, characterization, and identification of a sphingomyelin synthase from Pseudomonas aeruginosa. PlcH is a multifunctional enzyme. J Biol Chem 278 (2003) 32733-32743
14. Klement M.L., Ojemyr L., Tagscherer K.E., Widmalm G., and Wieslander A. A processive lipid glycosyltransferase in the small human pathogen Mycoplasma pneumoniae: involvement in host immune response. Mol Microbiol 65 (2007) 1444-1457
15. Kolter T. Lipids and lipidomics. Angew Chem Int Ed Engl 45 (2006) 5910-5911
16. Lagarde M., Geloen A., Record M., Vance D., and Spener F. Lipidomics is emerging. Biochim Biophys Acta 1634 (2003) 61
17. Wenk M.R. The emerging field of lipidomics. Nat Rev Drug Discov 4 (2005) 594-610
18. Han X., and Gross R.W. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 24 (2005) 367-412
19. Schiller J., Suss R., Fuchs B., Muller M., Zschornig O., and Arnold K. MALDI-TOF MS in lipidomics. Front Biosci 12 (2007) 2568-2579
20. Wenk M.R. Lipidomics of host-pathogen interactions. FEBS Lett 580 (2006) 5541-5551
21. Regula J.T., Ueberle B., Boguth G., Gorg A., Schnolzer M., Herrmann R., et al. Towards a two-dimensional proteome map of Mycoplasma pneumoniae. Electrophoresis 21 (2000) 3765-3780
22. Ueberle B., Frank R., and Herrmann R. The proteome of the bacterium Mycoplasma pneumoniae: comparing predicted open reading frames to identified gene products. Proteomics 2 (2002) 754-764
23. Huang Y., Shen J., Wang T., Yu Y.K., Chen F.F., and Yang J. A lipidomic study of the effects of N-methyl-N′-nitro-N-nitrosoguanidine on sphingomyelin metabolism. Acta Biochim Biophys Sin (Shanghai) 37 (2005) 515-524
24. Huang Y., Yang J., Shen J., Chen F.F., and Yu Y. Sphingolipids are involved in N-methyl-N′-nitro-N-nitrosoguanidine-induced epidermal growth factor receptor clustering. Biochem Biophys Res Commun 330 (2005) 430-438
25. Kacher Y., and Futerman A.H. Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options. FEBS Lett 580 (2006) 5510-5517
26. Kolter T., and Sandhoff K. Sphingolipid metabolism diseases. Biochim Biophys Acta 1758 (2006) 2057-2079
27. Zheng W., Kollmeyer J., Symolon H., Momin A., Munter E., Wang E., et al. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 1758 (2006) 1864-1884
28. Himmelreich R., Hilbert H., Plagens H., Pirkl E., Li B.C., and Herrmann R. Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res 24 (1996) 4420-4449
29. Grassme H., Cremesti A., Kolesnick R., and Gulbins E. Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 22 (2003) 5457-5470
30. Gulbins E. Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol Res 47 (2003) 393-399
31. Gulbins E., and Grassme H. Ceramide and cell death receptor clustering. Biochim Biophys Acta 1585 (2002) 139-145
32. Smith E.R., Jones P.L., Boss J.M., and Merrill A.H. Jr. Changing J774A.1 cells to new medium perturbs multiple signaling pathways, including the modulation of protein kinase C by endogenous sphingoid bases. J Biol Chem 272 (1997) 5640-5646
33. Smith E.R., and Merrill Jr. A.H. Differential roles of de novo sphingolipid biosynthesis and turnover in the "burst" of free sphingosine and sphinganine, and their 1-phosphates and N-acyl-derivatives, that occurs upon changing the medium of cells in culture. J Biol Chem 270 (1995) 18749-18758
34. Gygi S.P., Rochon Y., Franza B.R., and Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19 (1999) 1720-1730
35. Schenck M., Carpinteiro A., Grassme H., Lang F., and Gulbins E. Ceramide: physiological and pathophysiological aspects. Arch Biochem Biophys 462 (2007) 171-175
36. Ma X., Liu G., Wang S., Chen Z., Lai M., Liu Z., et al. Evaluation of sphingolipids changes in brain tissues of rats with pentylenetetrazol-induced kindled seizures using MALDI-TOF-MS. J Chromatogr B Analyt Technol Biomed Life Sci 859 (2007) 170-177
37. Sun G., Xu X., Wang Y., Shen X., Chen Z., and Yang J. Mycoplasma pneumoniae infection induces reactive oxygen species and DNA damage in A549 human lung carcinoma cells. Infect Immun 76 (2008) 4405-4413
38. Yang J., Hooper W.C., Phillips D.J., and Talkington D.F. Interleukin-1beta responses to Mycoplasma pneumoniae infection are cell-type specific. Microb Pathog 34 (2003) 17-25